L. GENTILINI; M. COSCIA; S. LAURETI; P. GIONCHETTI; F. RIZZELLO; C. CALABRESE; G. POGGIOLI, MUCINOUS ADENOCARCINOMA IN PERIANAL CROHN'S DISEASE AFTER BIOLOGICAL THERAPY: A FOUR CASES REPORT, in: Abstract book, «JOURNAL OF CROHN'S AND COLITIS», 2011, 5, pp. S137 - S137 (atti di: EUROPEAN CROHN'S AND COLITIS ORGANISATION, DUBLINO, 24-26 FEBBRAIO 2011) [atti di convegno-abstract]
M. COSCIA; L. GENTILINI; S. LAURETI; P. GIONCHETTI; F. RIZZELLO; C. CALABRESE; G. POGGIOLI, RISK OF PERMANENT STOMA IN CROHN'S COLITIS: A COMPARISON STUDY BETWEEN PRE-BIOLOGICAL ERA AND BIOLOGICAL ERA, in: Abstract book, «JOURNAL OF CROHN'S AND COLITIS», 2011, 5, pp. S82 - S82 (atti di: EUROPEAN CROHN'S AND COLITIS ORGANISATION, DUBLINO, 24-26 FEBBRAIO 2011) [atti di convegno-abstract]
Gionchetti P; Calabrese C; Tambasco R; Brugnera R; Straforini G; Liguori G; Fornarini GS; Riso D; Campieri M; Rizzello F., Role of conventional therapies in the era of biological treatment in Crohn's disease., «WORLD JOURNAL OF GASTROENTEROLOGY», 2011, 17, pp. 1797 - 1806 [articolo]
Orlando A; Armuzzi A; Papi C; Annese V; Ardizzone S; Biancone L; Bortoli A; Castiglione F; D'Incà R; Gionchetti P; Kohn A; Poggioli G; Rizzello F; Vecchi M; Cottone M., The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease, «DIGESTIVE AND LIVER DISEASE», 2011, 43, pp. 1 - 20 [articolo]
R. TAMBASCO; P. GIONCHETTI; G. STRAFORINI; R. BRUGNERA; C. CALABRESE; G. POGGIOLI; S. LAURETI; F. RIZZELLO; M. CAMPIERI, ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS, in: abstract book, «DIGESTIVE AND LIVER DISEASE», 2010, 42, pp. S128 - S128 (atti di: XVI NATIONAL CONGRESS OF DIGESTIVE DISEASE- ITALIAN FEDERATION OF SOCIETIES OF DIGESTIVE DISEASES (FISMAD), VERONA, 6-9 MARZO 2010) [atti di convegno-abstract]
Paolo Gionchetti; Fernando Rizzello; Rosy Tambasco; Giulia Straforini; Ramona Brugnera; Carlo Calabrese; Gilberto Poggioli; Silvio Laureti; Massimo Campieri, Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients, in: AGA Abstract, «GASTROENTEROLOGY», 2010, 138, Issue 5, Suppl 1, pp. 328 - 328 (atti di: digestive disease week, New Orleans (USA), 1-5 maggio 2010) [atti di convegno-abstract]
A. Agostini; F. Rizzello; G. Ravegnani; P. Gionchetti; R. Tambasco; G. Straforini; M. Ercolani; M. Campieri, Adult attachment and early parental experiences
in patients with Crohn’s Disease, «PSYCHOSOMATICS», 2010, 51, pp. 208 - 215 [articolo]
Turroni, Silvia; Vitali, Beatrice; Candela, Marco; Gionchetti, Paolo; Rizzello, Fernando; Campieri, Massimo; Brigidi, Patrizia, Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach, «WORLD JOURNAL OF GASTROENTEROLOGY», 2010, 16, pp. 30 - 41 [articolo]
Poggioli G; Laureti S; Pierangeli F; Bazzi P; Coscia M; Gentilini L; Gionchetti P; Rizzello F., Local injection of adalimumab for perianal Crohn's disease: better than infliximab?, «INFLAMMATORY BOWEL DISEASES», 2010, 16, pp. 1631 - 1631 [abstract]
Paolo Gionchetti; Giulia Straforini; Rosy Tambasco; Ramona Brugnera; Giulia Spuri Fornarini; Gilberto Poggioli; Silvio Laureti; Massimo Campieri; Fernando Rizzello, M1085 Use of Infliximab and Adalimumab in Refractory Pouchitis, in: AGA Abstract, «GASTROENTEROLOGY», 2010, 138, Issue 5, Supp. 1, pp. 238 - 238 (atti di: digestive disease week, new orleans (USA), 1-5 maggio 2010) [atti di convegno-abstract]
Tambasco R; Gionchetti P; Straforini G; Brugnera R; Spuri Fornarini G; Laureti S; Poggioli G; Campieri M; Rizzello F, OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS, in: Abstracts XVI National Congress of Digestive Diseases, Amsterdam, Elsevier Science, «DIGESTIVE AND LIVER DISEASE», 2010, 42, pp. s72 - s72 (atti di: XVI National Congress of Digestive Diseases - Italian Federation of Societies of Digestive Diseases - FISMAD, Verona, 6–9 Marzo 2010) [atti di convegno-abstract]
A. Agostini; F. Rizzello; G. Ravegnani; P. Gionchetti; R. Tambasco; M. Ercolani; M. Campieri, Parental Bonding and Inflammatory Bowel Disease, «PSYCHOSOMATICS», 2010, 51:1, pp. 14 - 21 [articolo]
Calabrese C; Spisni E; Liguori G; Lazzarini G; Valerii MC; Strillacci A; Gionchetti P; Pagotto U; Campieri M; Rizzello F., Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease, «ALIMENTARY PHARMACOLOGY & THERAPEUTICS», 2010, 32, pp. 603 - 611 [articolo]
Gionchetti P; Calabrese C; Tambasco R; Straforini G; Brugnera R; Spuri Fornarini G; Liguori G; Rizzello F, Probiotics in IBD: A critical review, «INFLAMMATORY BOWEL DISEASE MONITOR», 2010, 11, pp. 65 - 72 [articolo]
A. Strillacci; C. Griffoni; G. Lazzarini; M. C. Valerii; S. Di Molfetta; F.Rizzello; M. Campieri; M. P. Moyer; V. Tomasi; E. Spisni, Selective cyclooxygenase-2 (COX-2) silencing mediated by engineered Escherichia coli and RNA Interference induces anti-tumour effects in human colon cancer cells, «BRITISH JOURNAL OF CANCER», 2010, 103, pp. 86 - 975 [articolo]
